Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Chinese MedicineOpen Access

Impact of Traditional Chinese Medicine therapy focused on strengthening the body on postoperative recurrence and metastasis prevention in stage IIIA non-small cell lung cancer: a real-world retrospective cohort study

View Full Paper
Ask AI
Bookmark
Share

Authors

RQRuoyan QinYJYi JiangLSLiping Shen

Discussion

Loading...

Member takes

Overview

Retrospective cohort study finds TCM therapy improves disease-free survival in stage IIIA patients, suggesting potential benefits in postoperative care.

Key Points

  • TCM therapy resulted in a significantly longer median disease-free survival compared to standard treatment alone.
  • In the exposed group, 78% achieved 1-year disease-free survival rate compared to 63% in the non-exposed group.
  • The study involved 700 patients with stage IIIA non-small cell lung cancer, analyzed through retrospective cohort methods.
  • Reduced recurrence and metastasis associated with TCM therapy indicate a promising complement to conventional treatments.

Cite This Study

Qin et al. (2025) studied this question.

synapsesocial.com/papers/68c24364b210217d647a7285https://doi.org/10.1186/s13020-025-01195-x
View Full Paper
Ask AI
Bookmark
Share